Prostate-specific membrane antigen (PSMA) positron emission tomography/magnetic resonance imaging (PET/MRI) is a novel imaging technique with several potential applications in the prostate cancer (PCa) setting
Combined molecular and morphologic imaging modalities have emerged in recent years as an alternative...
Treatment of high-risk prostate cancer (HRPCa) is challenging. Local staging and metastatic evaluati...
INTRODUCTION: Prostate specific membrane antigen (PSMA) positron emission tomography (PET) with comp...
Prostate-specific membrane antigen (PSMA) positron emission tomography/magnetic resonance imaging (P...
Prostate cancer imaging has become an important diagnostic modality for tumor evaluation. Prostate-s...
Imaging has a central role in the context of focal therapy (FT) for prostate cancer (PCa). Prostate-...
Prostate-specific membrane antigen (PSMA) is highly expressed on most prostate cancer (PCa) cells, a...
Positron-emission tomography (PET) with prostate-specific membrane antigen (PSMA) has been increasin...
As precision medicine evolves, the contribution of molecular imaging to the management of prostate c...
In the past 10 yr, several agents based on prostate-specific membrane antigen (PSMA) for positron em...
Purpose Positron emission tomography using ligands targeting prostate specific membrane antigen has ...
The use of prostate-specific membrane antigen (PSMA) radiotracer in positron emission tomography (PE...
Molecular imaging with PET using an increasing list of bio-logically relevant radiotracers is paving...
OBJECTIVE: The purpose of this article is to describe the large number of radiotracers being evalu...
A total of 34 studies of prostate-specific membrane antigen PET in prostate cancer had systematic-se...
Combined molecular and morphologic imaging modalities have emerged in recent years as an alternative...
Treatment of high-risk prostate cancer (HRPCa) is challenging. Local staging and metastatic evaluati...
INTRODUCTION: Prostate specific membrane antigen (PSMA) positron emission tomography (PET) with comp...
Prostate-specific membrane antigen (PSMA) positron emission tomography/magnetic resonance imaging (P...
Prostate cancer imaging has become an important diagnostic modality for tumor evaluation. Prostate-s...
Imaging has a central role in the context of focal therapy (FT) for prostate cancer (PCa). Prostate-...
Prostate-specific membrane antigen (PSMA) is highly expressed on most prostate cancer (PCa) cells, a...
Positron-emission tomography (PET) with prostate-specific membrane antigen (PSMA) has been increasin...
As precision medicine evolves, the contribution of molecular imaging to the management of prostate c...
In the past 10 yr, several agents based on prostate-specific membrane antigen (PSMA) for positron em...
Purpose Positron emission tomography using ligands targeting prostate specific membrane antigen has ...
The use of prostate-specific membrane antigen (PSMA) radiotracer in positron emission tomography (PE...
Molecular imaging with PET using an increasing list of bio-logically relevant radiotracers is paving...
OBJECTIVE: The purpose of this article is to describe the large number of radiotracers being evalu...
A total of 34 studies of prostate-specific membrane antigen PET in prostate cancer had systematic-se...
Combined molecular and morphologic imaging modalities have emerged in recent years as an alternative...
Treatment of high-risk prostate cancer (HRPCa) is challenging. Local staging and metastatic evaluati...
INTRODUCTION: Prostate specific membrane antigen (PSMA) positron emission tomography (PET) with comp...